In this episode, she discusses how her team is helping employers make informed decisions on healthcare strategy, address common health issues in the workplace and embrace the emergence of precision medicine.
Danny Sands MD, MPH of Beth Israel Deaconess Medical Center joined us to talk about how our health care system is not working as well as it should for patients and clinicians, nor for the government, employers, and insurance plans that pay for it. We can do better by taking better advantage of technology, combined with the sociological change of viewing health care as a partnership rather than a one-sided chore. Patients and clinicians should be partners.
Dr. Sands is passionate about healthcare transformation, non-visit based care, collaboration in healthcare, and participatory medicine. For over twenty years he has worked at the intersection of health care, technology, and business.
It was Tom’s vision and leadership that resulted in the creation of IBI in 1995. Tom has guided IBI to become the leading research organization focused on health and productivity and has led to the growth of the organization to nearly 1,200 corporate members, representing more than 20 million U.S. workers.
Carrie Hurwitz Williams, Principal at McKesson Ventures, joined us for a conversation on emerging trends in precision medicine, pockets of adoption and organizations addressing business challenges facing the health care industry.
Carrie has nearly 15 years of healthcare experience from several vantage points within the healthcare industry. Prior to joining McKesson Ventures, she served as Vice President, Strategy and Business Development for San Francisco-based digital therapeutics pioneer Omada Health.
Bob Mehr is a business innovator and industry leader who began his career as a Compounding Pharmacist. Bob Mehr has been the President and CEO of Pure Integrative Pharmacy since 1999 opening 14 stores. His experience with precision prescribing goes beyond his practice and has had a tremendous impact on his own health.
‘A patient died right in front of me because they had the wrong medication. We need to stop practicing medicine like this, we need to be more precise. I opened my pharmacies because I wanted a change, and I wanted everyone to take advantage of it’ Bob Mehr, President, and CEO of Pure Integrative Pharmacy
Dr. Liam Brunham, Assistant Professor in the Department of Medicine at the University of British Columbia and a Principal Investigator at the UBC Centre for Heart and Lung Innovation join us for a conversation on adverse drug reactions, pharmacogenetics and iPSC.
Imagine being able to reprogram your cells to find the right medication for your heart. Understanding the biological and molecular processes underlying adverse drug reactions (ADRs) is fundamental to develop innovative approaches to prevent them. One of the most promising technologies to identify the genetic mechanisms behind ADRs are induced pluripotent stem cells (iPSCs).